Cancer Marker Pursuit Heats Up
March 15, 2011
The search for cancer biomarkers has proven to be a long, frustrating, and mainly fruitless exercise. Despite the substantial investment, no new markers suitable for large-scale screening protocols have achieved FDA approval. Yet, improvements in investigative tools, as well as innovative computer analysis, offer hope that the situation may be changing, and newly characterized candidates may prove to be clinically useful.
Read the full article
Strategies to Advance mAb Production
March 1, 2011
While approval of new therapeutic antibodies has not progressed as rapidly as was forecast 10 years ago, new products are moving through the pipeline. As always, bioprocessing, critical to antibody manufacture, is a key factor in the cost and efficiency of production.
Interviews with company officials and researchers engaged in bioprocessing showed how novel approaches to these challenges are moving the industry forward.